The Johns Hopkins University, School of Medicine
Baltimore, Maryland 21287
6 studies enrolling now · 21 studies all time
What they study most
Acute Coronary Syndrome, Acute Myocardial Infarction, Anemia, Sickle Cell, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anxiety Disorders, Cardiovascular Diseases, Chronic Hepatitis C, Coronary Artery Disease, Hormone Sensitive Prostate Cancer, Hypochondroplasia, Immunoglobulin A Nephropathy, Kidney Failure, Chronic
Studies at this site
- A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) — Recruiting now
- Trifecta-Kidney cfDNA-MMDx Study — Recruiting now
- Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts — Recruiting now
- A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months — Recruiting now
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
- A Multicenter Multinational Observational Study of Children With Hypochondroplasia — Recruiting now
- Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER) — Completed
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors — Running, not enrolling
- Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD — Running, not enrolling
- Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease — Completed
- MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma — Stopped early
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases — Running, not enrolling
- Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
- Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study — Stopped early
- Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease — Stopped early
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch — Completed
- PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples — Completed
- Effectiveness of a Family-Based Treatment for Preventing Anxiety Disorders in At-Risk Children — Completed
- Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer — Completed
- A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment — Completed
- Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients — Completed